# SODIUM PHENYLACETATE AND SODIUM BENZOATE
> **NDA215025** · New Drug Application · Sponsor: MAIA PHARMS INC · Approved 2021-06-10
## Drug
- **FDA Application Number:** NDA215025
- **Application type:** New Drug Application
- **Brand name:** SODIUM PHENYLACETATE AND SODIUM BENZOATE
- **Generic name:** SODIUM PHENYLACETATE AND SODIUM BENZOATE
- **Active ingredients:** SODIUM BENZOATE; SODIUM PHENYLACETATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** MAIA PHARMS INC
- **Manufacturer:** MAIA PHARMACEUTICALS
- **First approval:** 2021-06-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215025)
---
*AI Analytics · CC0 1.0*